arrow
J

Jun Goo Kang

Hallym University College of Medicine
H指数:26
被引数:2,757

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension

在二甲双胍和恩格列净25 mg基础上加用阿那格雷汀的疗效与安全性:一项为期24周的随机、双盲、安慰剂对照Ⅲ期试验及28周开放标签扩展研究

2026-04-240
PRE
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double-blind, multicentre, therapeutic confirmatory phase 3 clinical trial
2025-12-010
OAAI
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study

固定剂量联合达格列净和利格列汀 (AJU-A51) 对2型糖尿病患者的疗效和安全性: 一项多中心,随机,双盲,平行组,安慰剂对照的III期研究

2024-10-071
OAAI
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)

吉格列汀联合达格列净和二甲双胍对2型糖尿病患者的疗效: 一项随机、双盲、安慰剂对照研究 (SOLUTION)

2023-06-301
OAAI